Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGN Argenica Therapeutics Limited

0.035 (5.47%)
Mar 04 2024 - Closed
Delayed by 20 minutes

Argenica Therapeutics Financial Summary

The current AGN market cap is 67.16M. The company's latest EPS is AUD -0.0484 and P/E is -13.84.

Year End June 29 2023 20202020202120222023
Total Revenue 00296k259k1.75M
Operating Income -383k0-614k-4.09M-4.88M
Net Income -383k0-1.03M-4.09M-4.82M
Year End June 29 2023 20202020202120222023
Total Assets 378k7.52M7.27M9.04M9.54M
Total Liabilities 359k58k426k736k1.88M
Total Equity 19k7.46M6.85M8.31M7.67M

Cash Flow

Year End June 29 2023 20202020202120222023
Operating -59k N/A -1.05M-3.36M-3.3M
Investing N/A N/A N/A N/A -50k
Financing 401k N/A 7.85M5.13M3.73M
Market Cap 67.16M
Price to Earnings Ratio -13.84
Price to Sales Ratio 38.07
Price to Cash Ratio 7.17
Price to Book Ratio 8.7
Dividend Yield -

Share Statistics

Shares Outstanding 99.5M
Average Volume (1 week) 155.69k
Average Volume (1 Month) 111.15k
52 Week Change 50.00%
52 Week High 0.75
52 Week Low 0.295
Spread (Intraday) 0.04 (5.04%)

Company Info

Company Name Argenica Therapeutics Limited
Address unit 4
nedlands, western australia 6009
Website https://
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock